{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T01:20:31Z","timestamp":1771464031838,"version":"3.50.1"},"reference-count":41,"publisher":"Asia Pacific Academy of Ophthalmology","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asia Pac J Ophthalmol (Phila)"],"published-print":{"date-parts":[[2018]]},"DOI":"10.22608\/apo.201855","type":"journal-article","created":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T11:23:25Z","timestamp":1523273005000},"source":"Crossref","is-referenced-by-count":21,"title":["Familial Exudative Vitreoretinopathy: Pathophysiology, Diagnosis, and Management"],"prefix":"10.22608","member":"9895","published-online":{"date-parts":[[2018]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/0002-9394(69)91237-9","article-title":"Familial exudative vitreoretinopathy","volume":"68","author":"Criswick","year":"1969","unstructured":"1. Criswick V, Schepens CL. Familial exudative vitreoretinopathy. Am J Ophthalmol. 1969;68:578\u2012594.","journal-title":"Am J Ophthalmol"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/humu.21250","article-title":"Overview of the mutation spectrum in familial exudative vitreoretinopathy and Norrie disease with identification of 21 novel variants in FZD4, LRP5, and NDP","volume":"31","author":"Nikopoulos","year":"2010","unstructured":"2. Nikopoulos K, Venselaar H, Collin RWJ, et al. Overview of the mutation spectrum in familial exudative vitreoretinopathy and Norrie disease with identification of 21 novel variants in FZD4, LRP5, and NDP. Hum Mutat. 2010;31:656\u2012666.","journal-title":"Hum Mutat"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1136\/bjo.2010.190116","article-title":"The role of Frizzled-4 mutations in familial exudative vitreoretinopathy and Coats disease","volume":"95","author":"Robitaille","year":"2011","unstructured":"3. Robitaille JM, Zheng B, Wallace K, et al. The role of Frizzled-4 mutations in familial exudative vitreoretinopathy and Coats disease. Br J Ophthalmol. 2011;95:574\u2012579.","journal-title":"Br J Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/eye.2014.70","article-title":"Familial exudative vitreoretinopathy and related retinopathies","volume":"29","author":"Gilmour","year":"2015","unstructured":"4. Gilmour DF. Familial exudative vitreoretinopathy and related retinopathies. Eye (Lond). 2015;29:1\u201214.","journal-title":"Eye (Lond)"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1086\/425080","article-title":"Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5","volume":"75","author":"Jiao","year":"2004","unstructured":"5. Jiao X, Ventruto V, Trese MT, et al. Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5. Am J Hum Genet. 2004;75:878\u2012884.","journal-title":"Am J Hum Genet"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cell.2009.07.048","article-title":"TSPAN12 regulates retinal vascular development by promoting Norrin- but not Wnt-induced FZD4\/\u03b2-catenin signaling","volume":"139","author":"Junge","year":"2009","unstructured":"6. Junge HJ, Yang S, Burton JB, et al. TSPAN12 regulates retinal vascular development by promoting Norrin- but not Wnt-induced FZD4\/\u03b2-catenin signaling. Cell. 2009;139:299\u2012311.","journal-title":"Cell"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ajhg.2009.12.016","article-title":"Next-generation sequencing of a 40 Mb linkage interval reveals TSPAN12 mutations in patients with familial exudative vitreoretinopathy","volume":"86","author":"Nikopoulos","year":"2010","unstructured":"7. Nikopoulos K, Gilissen C, Hoischen A, et al. Next-generation sequencing of a 40 Mb linkage interval reveals TSPAN12 mutations in patients with familial exudative vitreoretinopathy. Am J Hum Genet. 2010;86:240\u2012247.","journal-title":"Am J Hum Genet"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ajhg.2010.01.012","article-title":"Mutations in TSPAN12 cause autosomal-dominant familial exudative vitreoretinopathy","volume":"86","author":"Poulter","year":"2010","unstructured":"8. Poulter JA, Ali M, Gilmour DF, et al. Mutations in TSPAN12 cause autosomal-dominant familial exudative vitreoretinopathy. Am J Hum Genet. 2010;86:248\u2012253.","journal-title":"Am J Hum Genet"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1167\/iovs.11-8629","article-title":"Recessive mutations in TSPAN12 cause retinal dysplasia and severe familial exudative vitreoretinopathy (FEVR)","volume":"53","author":"Poulter","year":"2012","unstructured":"9. Poulter JA, Davidson AE, Ali M, et al. Recessive mutations in TSPAN12 cause retinal dysplasia and severe familial exudative vitreoretinopathy (FEVR). Invest Ophthalmol Vis Sci. 2012;53:2873\u20122879.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"9856","DOI":"10.1073\/pnas.1220864110","article-title":"ZNF408 is mutated in familial exudative vitreoretinopathy and is crucial for the development of zebrafish retinal vasculature","volume":"110","author":"Collin","year":"2013","unstructured":"10. Collin RWJ, Nikopoulos K, Dona M, et al. ZNF408 is mutated in familial exudative vitreoretinopathy and is crucial for the development of zebrafish retinal vasculature. Proc Natl Acad Sci U S A. 2013;110:9856\u20129861.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"26564","DOI":"10.1038\/srep26564","article-title":"Identification of novel KIF11 mutations in patients with familial exudative vitreoretinopathy and a phenotypic analysis","volume":"6","author":"JK","year":"2016","unstructured":"11. Li JK, Fei P, Li Y, et al. Identification of novel KIF11 mutations in patients with familial exudative vitreoretinopathy and a phenotypic analysis. Sci Rep. 2016;6:26564.","journal-title":"Sci Rep"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1001\/archophthalmol.2009.322","article-title":"Clinical presentation and genetic correlation of patients with mutations affecting the FZD4 gene","volume":"127","author":"Drenser","year":"2009","unstructured":"12. Drenser KA, Dailey W, Vinekar A, et al. Clinical presentation and genetic correlation of patients with mutations affecting the FZD4 gene. Arch Ophthalmol. 2009;127:1649\u20121654.","journal-title":"Arch Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1001\/jamaophthalmol.2014.2814","article-title":"Phenotypic overlap between familial exudative vitreoretinopathy and microcephaly, lymphedema, and chorioretinal dysplasia caused by kif11 mutations","volume":"132","author":"Robitaille","year":"2014","unstructured":"13. Robitaille JM, Gillett RM, LeBlanc MA, et al. Phenotypic overlap between familial exudative vitreoretinopathy and microcephaly, lymphedema, and chorioretinal dysplasia caused by kif11 mutations. JAMA Ophthalmol. 2014;132:1393\u20121399.","journal-title":"JAMA Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cell.2009.07.047","article-title":"Norrin, Frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization","volume":"139","author":"Ye","year":"2009","unstructured":"14. Ye X, Wang Y, Cahill H, et al. Norrin, Frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization. Cell. 2009;139:285\u2012298.","journal-title":"Cell"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0092-8674(04)00216-8","article-title":"Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair","volume":"116","author":"Xu","year":"2004","unstructured":"15. Xu Q, Wang Y, Dabdoub A, et al. Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell. 2004;116:883\u2012895.","journal-title":"Cell"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1093\/hmg\/ddn047","article-title":"A model for familial exudative vitreoretinopathy caused by LPR5 mutations","volume":"17","author":"Xia","year":"2008","unstructured":"16. Xia CH, Liu H, Cheung D, et al. A model for familial exudative vitreoretinopathy caused by LPR5 mutations. Hum Mol Genet. 2008;17: 1605\u20121612.","journal-title":"Hum Mol Genet"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1167\/iovs.05-0174","article-title":"Role of the Norrie disease pseudoglioma gene in sprouting angiogenesis during development of the retinal vasculature","volume":"46","author":"Luhmann","year":"2005","unstructured":"17. Luhmann UFO, Lin J, Acar N, et al. Role of the Norrie disease pseudoglioma gene in sprouting angiogenesis during development of the retinal vasculature. Invest Ophthalmol Vis Sci. 2005;46:3372\u20123382.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.18632\/oncotarget.1490","article-title":"Impaired angiogenesis and tumor development by inhibition of the mitotic kinesin Eg5","volume":"4","author":"Exertier","year":"2013","unstructured":"18. Exertier P, Javerzat S, Wang B, et al. Impaired angiogenesis and tumor development by inhibition of the mitotic kinesin Eg5. Oncotarget. 2013;4: 2302\u20122316.","journal-title":"Oncotarget"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1136\/bjo.64.2.112","article-title":"Autosomal dominant exudative vitreoretinopathy","volume":"64","author":"Ober","year":"1980","unstructured":"19. Ober R, Bird A, Hamilton A, et al. Autosomal dominant exudative vitreoretinopathy. Br J Ophthalmol. 1980;64:112\u2012120.","journal-title":"Br J Ophthalmol"},{"key":"ref19","first-page":"323","article-title":"Familial exudative vitreoretinopathy (FEVR). Clinical profile and management.","volume":"51","author":"Shukla","year":"2003","unstructured":"20. Shukla D, Singh J, Sudheer G, et al. Familial exudative vitreoretinopathy (FEVR). Clinical profile and management. Indian J Ophthalmol. 2003;51: 323\u2012328.","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1086\/383202","article-title":"Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q","volume":"74","author":"Toomes","year":"2004","unstructured":"21. Toomes C, Bottomley HM, Jackson RM, et al. Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q. Am J Hum Genet. 2004;74:721\u2012730.","journal-title":"Am J Hum Genet"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/13816810802464312","article-title":"Phenotypic overlap of familial exudative vitreoretinopathy (FEVR) with persistent fetal vasculature (PFV) caused by FZD4 mutations in two distinct pedigrees","volume":"30","author":"Robitaille","year":"2009","unstructured":"22. Robitaille JM, Wallace K, Zheng B, et al. Phenotypic overlap of familial exudative vitreoretinopathy (FEVR) with persistent fetal vasculature (PFV) caused by FZD4 mutations in two distinct pedigrees. Ophthalmic Genet. 2009;30:23\u201230.","journal-title":"Ophthalmic Genet"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ophtha.2013.08.010","article-title":"High prevalence of peripheral retinal vascular anomalies in family members of patients with familial exudative vitreoretinopathy","volume":"121","author":"Kashani","year":"2014","unstructured":"23. Kashani AH, Learned D, Nudleman E, et al. High prevalence of peripheral retinal vascular anomalies in family members of patients with familial exudative vitreoretinopathy. Ophthalmology. 2014;121:262\u2012268.","journal-title":"Ophthalmology"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1167\/iovs.14-15680","article-title":"Molecular characterization of FZD4, LRP5, and TSPAN12 in familial exudative vitreoretinopathy","volume":"56","author":"Seo","year":"2015","unstructured":"24. Seo SH, Yu YS, Park SW, et al. Molecular characterization of FZD4, LRP5, and TSPAN12 in familial exudative vitreoretinopathy. Invest Ophthalmol Vis Sci. 2015;56:5143\u20125151.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1167\/iovs.14-16065","article-title":"Next-generation sequencing and novel variant determination in a cohort of 92 familial exudative vitreoretinopathy patients","volume":"56","author":"Salvo","year":"2015","unstructured":"25. Salvo J, Lyubasyuk V, Xu M, et al. Next-generation sequencing and novel variant determination in a cohort of 92 familial exudative vitreoretinopathy patients. Invest Ophthalmol Vis Sci. 2015;56:1937\u20121946.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1001\/archopht.125.2.225","article-title":"Retinal phenotype-genotype correlation of pediatric patients expressing mutations in the Norrie disease gene","volume":"125","author":"WC","year":"2007","unstructured":"26. Wu WC, Drenser K, Trese M, et al. Retinal phenotype-genotype correlation of pediatric patients expressing mutations in the Norrie disease gene. Arch Ophthalmol. 2007;125:225\u2012230.","journal-title":"Arch Ophthalmol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.1167\/iovs.08-3320","article-title":"Clinical and molecular evaluation of probands and family members with familial exudative vitreoretinopathy","volume":"50","author":"Boonstra","year":"2009","unstructured":"27. Boonstra FN, van Nouhuys EC, Schuil J, et al. Clinical and molecular evaluation of probands and family members with familial exudative vitreoretinopathy. Invest Ophthalmol Vis Sci. 2009;50:4379\u20124385.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s00417-008-0949-6","article-title":"Rapid regression of retinal hemorrhage and neovascularization in a case of familial exudative vitreoretinopathy treated with intravitreal bevacizumab","volume":"246","author":"Tagami","year":"2008","unstructured":"28. Tagami M, Kusuhara S, Honda S, et al. Rapid regression of retinal hemorrhage and neovascularization in a case of familial exudative vitreoretinopathy treated with intravitreal bevacizumab. Graefes Arch Clin Exp Ophthalmol. 2008;246:1787\u20121789.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1016\/j.ophtha.2011.06.020","article-title":"Clinical presentation of familial exudative vitreoretinopathy","volume":"118","author":"Ranchod","year":"2011","unstructured":"29. Ranchod TM, Ho LY, Drenser KA, et al. Clinical presentation of familial exudative vitreoretinopathy. Ophthalmology. 2011;118:2070\u20122075.","journal-title":"Ophthalmology"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S0161-6420(98)96002-X","article-title":"Familial exudative vitreoretinopathy: results of surgical management","volume":"105","author":"SD","year":"1998","unstructured":"30. Pendergast SD, Trese MT. Familial exudative vitreoretinopathy: results of surgical management. Ophthalmology. 1998;105:1015\u20121023.","journal-title":"Ophthalmology"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/S0161-6420(99)90268-3","article-title":"Vitrectomy for rhegmatogenous or tractional retinal detachment with familial exudative vitreoretinopathy","volume":"106","author":"Ikeda","year":"1999","unstructured":"31. Ikeda T, Fujikado T, Tano Y, et al. Vitrectomy for rhegmatogenous or tractional retinal detachment with familial exudative vitreoretinopathy. Ophthalmology. 1999;106:1081\u20121085.","journal-title":"Ophthalmology"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/IAE.0b013e31821c3ec5","article-title":"Clinical characteristics and surgical management of familial exudative vitreoretinopathy-associated rhegmatogenous retinal detachment","volume":"32","author":"Chen","year":"2012","unstructured":"32. Chen SN, Hwang JF, Lin CJ. Clinical characteristics and surgical management of familial exudative vitreoretinopathy-associated rhegmatogenous retinal detachment. Retina. 2012;32:220\u2012225.","journal-title":"Retina"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1016\/j.ophtha.2014.05.029","article-title":"Diversity of retinal vascular anomalies in patients with familial exudative vitreoretinopathy","volume":"121","author":"Kashani","year":"2014","unstructured":"33. Kashani AH, Brown KT, Chang E, et al. Diversity of retinal vascular anomalies in patients with familial exudative vitreoretinopathy. Ophthalmology. 2014;121:2220\u20122227.","journal-title":"Ophthalmology"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1016\/j.ophtha.2015.07.024","article-title":"Familial exudative vitreoretinopathy spectral-domain optical coherence tomography of the vitreoretinal interface, retina, and choroid","volume":"122","author":"Yonekawa","year":"2015","unstructured":"34. Yonekawa Y, Thomas BJ, Drenser KA, et al. Familial exudative vitreoretinopathy spectral-domain optical coherence tomography of the vitreoretinal interface, retina, and choroid. Ophthalmology. 2015;122: 2270\u20122277.","journal-title":"Ophthalmology"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1001\/archopht.1985.01050020090029","article-title":"The histopathology of familial exudative vitreoretinopathy: a report of two cases","volume":"103","author":"Boldrey","year":"1985","unstructured":"35. Boldrey EE, Egbert P, Gass JDM, et al. The histopathology of familial exudative vitreoretinopathy: a report of two cases. Arch Ophthalmol. 1985; 103:238\u2012241.","journal-title":"Arch Ophthalmol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/IAE.0b013e3181679bf6","article-title":"Treatment of vascularly active familial exudative vitreoretinopathy with pegaptanib sodium (Macugen).","volume":"28","author":"Quiram","year":"2008","unstructured":"36. Quiram PA, Drenser KA, Lai MM, et al. Treatment of vascularly active familial exudative vitreoretinopathy with pegaptanib sodium (Macugen). Retina. 2008;28(Suppl 3):8\u201212.","journal-title":"Retina","ISSN":"https:\/\/id.crossref.org\/issn\/0275-004X","issn-type":"print"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.ajo.2014.08.009","article-title":"Surgical outcomes of progressive tractional retinal detachment associated with familial exudative vitreoretinopathy","volume":"158","author":"Yamane","year":"2014","unstructured":"37. Yamane T, Yokoi T, Nakayama Y, et al. Surgical outcomes of progressive tractional retinal detachment associated with familial exudative vitreoretinopathy. Am J Ophthalmol. 2014;158:1049\u20121055.","journal-title":"Am J Ophthalmol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0002-9394(14)76893-X","article-title":"Signs, complications, and platelet aggregation in familial exudative vitreoretinopathy","volume":"111","author":"van Nouhuys","year":"1991","unstructured":"38. van Nouhuys CE. Signs, complications, and platelet aggregation in familial exudative vitreoretinopathy. Am J Ophthalmol. 1991;111:34\u201241.","journal-title":"Am J Ophthalmol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0002-9394(14)72661-3","article-title":"Improved surgical treatment of familial exudative vitreoretinopathy in children","volume":"120","author":"Glazer","year":"1995","unstructured":"39. Glazer LC, Maguire A, Blumenkranz MS, et al. Improved surgical treatment of familial exudative vitreoretinopathy in children. Am J Ophthalmol. 1995; 120:471\u2012479.","journal-title":"Am J Ophthalmol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/BF00947005","article-title":"Familial exudative vitreoretinopathy: surgical intervention and visual acuity outcomes","volume":"235","author":"Shubert","year":"1997","unstructured":"40. Shubert A, Tasman W. Familial exudative vitreoretinopathy: surgical intervention and visual acuity outcomes. Graefes Arch Clin Exp Ophthalmol. 1997;235:490\u2012493.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1097\/IAE.0000000000000961","article-title":"Surgical management of advanced familial exudative vitreoretinopathy with complications","volume":"36","author":"Fei","year":"2016","unstructured":"41. Fei P, Yang W, Zhang Q, et al. Surgical management of advanced familial exudative vitreoretinopathy with complications. Retina. 2016;36:1480\u20121485.","journal-title":"Retina"}],"container-title":["Asia-Pacific Journal of Ophthalmology"],"original-title":[],"deposited":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T13:14:53Z","timestamp":1561468493000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/apjoo\/Abstract\/2018\/05000\/Familial_Exudative_Vitreoretinopathy_.9.aspx"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":41,"URL":"https:\/\/doi.org\/10.22608\/apo.201855","relation":{},"ISSN":["2162-0989","2162-0989"],"issn-type":[{"value":"2162-0989","type":"print"},{"value":"2162-0989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}